ReposiTrak (NYSE:TRAK) CEO Sells $112,575.00 in Stock

ReposiTrak Inc. (NYSE:TRAKGet Free Report) CEO Randall Fields sold 7,500 shares of ReposiTrak stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $15.01, for a total transaction of $112,575.00. Following the sale, the chief executive officer owned 20,000 shares in the company, valued at approximately $300,200. This represents a 27.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

ReposiTrak Price Performance

Shares of NYSE TRAK traded up $0.03 during midday trading on Tuesday, reaching $15.05. 61,319 shares of the company traded hands, compared to its average volume of 52,897. ReposiTrak Inc. has a 52 week low of $13.86 and a 52 week high of $25.01. The firm has a market capitalization of $275.17 million, a P/E ratio of 43.00 and a beta of 0.44. The stock’s 50-day moving average is $15.91. The company has a current ratio of 6.09, a quick ratio of 6.09 and a debt-to-equity ratio of 0.01.

ReposiTrak (NYSE:TRAKGet Free Report) last released its quarterly earnings results on Monday, September 29th. The company reported $0.09 EPS for the quarter. ReposiTrak had a net margin of 30.55% and a return on equity of 14.25%. The company had revenue of $5.76 million for the quarter.

Institutional Trading of ReposiTrak

Several institutional investors and hedge funds have recently bought and sold shares of the stock. BNP Paribas Financial Markets raised its holdings in ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company’s stock worth $32,000 after buying an additional 634 shares during the period. Ingalls & Snyder LLC raised its holdings in shares of ReposiTrak by 1.3% during the second quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company’s stock valued at $3,905,000 after acquiring an additional 2,554 shares during the period. Tower Research Capital LLC TRC raised its stake in ReposiTrak by 397.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company’s stock valued at $71,000 after purchasing an additional 2,892 shares during the period. Ellsworth Advisors LLC raised its stake in ReposiTrak by 10.6% during the 1st quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company’s stock valued at $634,000 after purchasing an additional 2,997 shares during the period. Finally, American Century Companies Inc. raised its stake in ReposiTrak by 17.4% during the 2nd quarter. American Century Companies Inc. now owns 23,344 shares of the company’s stock valued at $459,000 after purchasing an additional 3,455 shares during the period. Institutional investors and hedge funds own 27.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of ReposiTrak in a research note on Wednesday, October 8th. Wall Street Zen cut shares of ReposiTrak from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Read Our Latest Report on ReposiTrak

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Featured Stories

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Receive News & Ratings for ReposiTrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReposiTrak and related companies with MarketBeat.com's FREE daily email newsletter.